Athanor Capital, LP Kala Pharmaceuticals, Inc. Transaction History

Athanor Capital, LP

  • $24.6 Million
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$6.24 - $9.58 $228,720 - $351,145
-36,654 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$6.28 - $8.79 $79,862 - $111,782
12,717 Added 53.13%
36,654 $249,000
Q3 2020

Nov 16, 2020
SELL
$7.5 - $11.11 $191,167 - $283,182
-25,489 Reduced 51.57%
23,937 $180,000
Q2 2020

Aug 13, 2020
BUY
$8.33 - $13.79 $411,718 - $681,584
49,426 New
49,426 $519,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $9.96M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Athanor Capital, LP Portfolio

Follow Athanor Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Athanor Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email